MEDIANA Co.,Ltd (KOSDAQ:041920)
8,200.00
+40.00 (0.49%)
At close: Sep 11, 2026
MEDIANA Co.,Ltd Revenue
MEDIANA Co.,Ltd had revenue of 21.14B KRW in the quarter ending June 30, 2026, with 34.81% growth. This brings the company's revenue in the last twelve months to 71.45B, up 23.49% year-over-year. In the year 2025, MEDIANA Co.,Ltd had annual revenue of 64.94B with 13.86% growth.
Revenue (ttm)
71.45B
Revenue Growth
+23.49%
P/S Ratio
2.12
Revenue / Employee
438.37M
Employees
163
Market Cap
151.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 64.94B | 7.91B | 13.86% |
| Dec 31, 2024 | 57.04B | -21.38B | -27.27% |
| Dec 31, 2023 | 78.42B | 10.07B | 14.74% |
| Dec 31, 2022 | 68.35B | 11.54B | 20.32% |
| Dec 31, 2021 | 56.80B | -10.72B | -15.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRGEM | 109.45B |
| JPI Healthcare | 46.86B |
| L&K Biomed | 39.94B |
| ASTERASYS Co.,Ltd | 39.61B |
| Hironic | 37.10B |
| SELVAS Healthcare | 31.69B |
| Remed | 27.05B |
| Next Biomedical | 17.79B |